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The abnormal or excessive fat accumulation that impairs health is one of the criteria that fulfills obesity.
According to epidemiological data, obesity has become a worldwide public health problem that in turn
would trigger additional pathologies such as cardiorespiratory dysfunctions, cancer, gastrointestinal
disturbances, depression, sleep disorders, just to mention a few. Then, the search for a therapeutical
intervention aimed to prevent and manage obesity has been the focus of study during the last years. As
one can assume, the increased prevalence of obesity has translated to search of efficient pharmaceuticals
designed to manage this health issue. However, to further complicate the scenario, scientific literature
has described that obesity is the result of interaction between multiple events. Therefore, pharmaco-
logical approaches have faced a serious challenge for develop the adequate treatment. Here, we argue
that a wide range of non-pharmacological/invasive techniques can be used to manage obesity, such as
diets, cognitive behavioral interventions, exercise and transcranial direct current stimulation. Combining
these techniques may allow improving quality of life of obese patients.
© 2018 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights
reserved.1. Introduction
Obesity is health world-wide problem that has been defined as
excessive accumulation of fat in the body. Classification of normal,
overweight or obese patients include several anthropometricas Moleculares e Integrativas,
Universidad Anahuac Mayab,
, C.P. 97310, Merida, Yucatan,
llo-Rodríguez).
ition and Metabolism. Published bcriteria, such as bodymass index (BMI)which categorizes patients as
obese if this anthropometric measurement is greater than 30 kg/m2
(Fig. 1) [1].
In addition, it has been reported that obesity is considered as
an epidemy in several countries, including the United States of
America [2e4] causing multiple health problems such as cancer,
heart diseases, depression, sleep disorders, among other issues
[5e8]. On the other hand, the etiology of obesity is complex and
involves different elements such as diet, socioeconomic status,
family influence, cultural aspects, lifestyle, etc [9e12]. Fory Elsevier Ltd. All rights reserved.
Fig. 1. Classification of normal, overweight or obese patients by using body mass index (BMI) criteria. According to standardized diagnostical procedures, patient fulfills obese
profile if BMI is greater than 30 kg/m2.
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strated that endocrine-disrupting compounds named “obes-
ogens” are also linked to weight gain [13,14]. Moreover, gut
microbiota has been suggested as a critical element in the
development of obesity [15e17].
Taking together, the management of obesity requires a multi-
disciplinary approach. In the midst of a plethora of therapeutic
intervention for obesity, pharmacological intervention is one of the
most proposed approaches [18e21]. However, it has been demon-
strated that many patients are still unable to reach clinically
meaningful improvements. Thus, additional therapeutic in-
terventions should be considered for preventive and modifiable
obesity.
2. Obesity
Obesity is a medical condition that the World Health Organi-
zation defines as abnormal or excessive fat accumulation that may
impair health [1]. Patients are generally considered obese when
body mass index (BMI) is over 30 kg/m2 [22]. Moreover, obesity is a
risk factor for diabetes type 2, hypertension, dyslipidemia and other
cardiovascular diseases, as well as cancer, obstructive sleep apnea
and psychological problems, just to mention a few health distur-
bances [23,24]. The literature suggest that energy imbalance be-
tween calories consumed and calories expended plays a critical role
in genesis of obesity as well as genetic or endocrine conditions and
certain drugs also are linked with obesity [2].
3. Non-pharmacological interventions for obesity
3.1. Diets
Strategies to treat obesity have been focused on lifestyle sig-
nificant modifications, including diets [25,26]. In this regard, diets
enriched with vegetables and fruit consumption over a long-term
period represent a positive outcome regarding health benefits
[27e31]. However, several weight-management diets have limited
positive results [32,33].
3.2. Cognitive-behavioral interventions against obesity
Beyond identification of the multiple overlapping factors of
obesity, one indisputable variable that contributes to the etiology ofthis disorder is the lifestyle [34,35]. Although is widely assumed
that obesity might be addressed by solid foundations of healthy
behaviors, healthy eating guidelines are in most of the cases un-
known in general population [36]. As one can assume, the defiance
for understanding the underpinnings of development of unhealthy
behaviors will provide invaluable support for behavior in-
terventions. By promoting health behaviors, such as choosing fruit
and vegetables over processed foods, significant advances in
behavior changes could be achieved. Several behavioral approaches
have been effective for treating health issues, for example the
Theory of Planned Behavior [37,38]. In this regard, Hamiltion and
coworkers (2013) showed that according to this approach, ele-
ments which influence mothers' decisions about their child's
adequate physical activity [34]. In sum, this intervention suggests
that different roles of psychosocial factors exert critical relevance in
mothers' decisions regarding their child engages in active lifestyle
behaviors. The design of interventions aiming to reduce the con-
sumption of unhealthy foods, apart from hypocaloric diets, should
also promote health behaviors aimed to strengthen a balanced
lifestyle.
3.3. Exercise as treatment in obesity
The recent findings conclude that physical exercise has signifi-
cant effects on both physical and psychological health [39,40]. In
this regard, physical exercise done voluntarily or being prescribed
can be used as a treatment for obesity. Here, wewould like to clarify
some terms used in this review. Budde et al. [41] proposed defini-
tions to differentiate physical activity from exercise and fitness. The
terms “exercise”’ and “training” are both defined as a structured,
planned and repetitive progress to maintain or achieve physical
fitness, although training is understood as a more chronic type of
exercise [42]. The components that aim at the maintenance or
achievement of physical fitness are related to health: For example,
cardiorespiratory endurance or body composition, as well as
strength and muscular flexibility [43]. Physical activity, in contrast,
is defined as bodily movement which results in energy expendi-
ture, but not with the goal of achieving or maintaining physical
fitness [44].
The overall goal of exercise in the treatment or prevention of
obesity is weight loss. To approach this goal, the Institute of
Medicine of The National Academies of Science published the
recommendation to undertake 60 min of moderate intensity
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intake [45]. Similarly, The American College of Sports Medicine
recommend exercise at a frequency of three to five times per week
on 55/65%e90% of the maximum heart rate with 20e60 min of
continuous or intermittent aerobic activity, but at least 150 min of
aerobic exercise per week to develop and maintain a healthy
lifestyle [46].
The physical benefits of an exercise training in obese patients
are mainly described in a change in the metabolism, such as an
improved liver function and hormone functions, like an increased
insulin and leptin sensitivity as well as increased ghrelin levels
[47e50]. Ghrelin has been shown to be a potent orexigenic hor-
mone, which increases at the time of weight loss, which could
explain the weight regain of obese patients after completing a strict
dietary intervention [51e53]. The abovementioned hormones play
a role in regulating satiety, hunger and energy balance and have
shown to be regulated through exercise, for example within a 12-
month programme of dietary and exercise-induced weight loss.
The researchers concluded that greater weight loss could be asso-
ciated with increased ghrelin concentrations, but could not detect
any difference in the exercise or dietary restriction group [54].
Further research emphasizes the need for further research, since
most of the published studies concerning the metabolic effects of
exercise have been conducted with healthy participants but less
with obese patients, since themetabolic changes caused by exercise
seem to be different in obese patients [55].
Another interesting question is the period for an exercise
regimen to obtain the highest weight loss. Iwayama et al. [56]
recommend completing an exercise intervention before breakfast,
because the 24-h fat oxidation increases more when exercise is
performed before breakfast, although the study was conducted
with non-obese individuals. In contrast to this statement, a study
on obese mice has shownmore effective weight loss when exercise
is undertaken at noon or in the evening in combinationwith energy
intake before the exercise [57]. A possible combination of the
abovementioned studies was published from Sasaki and coworkers
[57], with high fat diet induced obese mice, in which the re-
searchers propose that morning exercise could prevent obesity and
evening exercise may counteract fat deposition. The contrary out-
comes of the abovementioned studies implicate a need for further
research, but all researchers concluded significant effects of exer-
cise on obesity independent of the period.
On the other hand, Jakicic et al. [58] published a study to
compare effects on different durations and intensities of aerobic
exercise which endured for 12 months, and stated that the greatest
impact on weight loss was achieved through a combination of a
decrease of caloric intake and exercise. Since the main goal of an
exercise treatment for obesity is weight loss, most studies
comparing different exercise types, such as resistance or aerobic
exercise, stated different outcomes, but all within a beneficial
character for obesity symptoms [58e60]. Hence, we can conclude
that it is not the mode of intervention, but the duration, which is of
importance for a prolonged positive effect on the symptoms. Most
research, however, suggests that a moderate intensity should be
upheld. Lastly, Decker and Ekkekakis [61] compared the subjective
felt pleasure and enjoyment of high-intensity interval exercise and
moderate-intensity continuous exercise and stated that low-active
obese women significantly preferred the moderate intense exercise
form. This information is important for caregivers developing ex-
ercise programmes as a treatment form for obesity, to reduce the
risk of dropout and ensure the compliance of obese patients. Even if
a high intensity aerobic exercise could be more effective, the pa-
tient's compliance and subjective felt pleasure for the prescribed
method could be of more importance for the positive outcome of an
intervention [61].3.4. Transcranial direct current stimulation and obesity
According to neuroimaging studies, obese subjects have an
imbalance in the activity of pre-frontal and limbic circuits [62],
corroborating data from studies that reported cognitive and reward
brain mechanisms related to eating behavior [62e64]. Research in
brain areas of obese patients indicates an abnormal activity in the
left dorsolateral prefrontal cortex (DLPFC) involved in behavioral
regulation, taste, and rewards processing [65e72]. In this regard,
several studies have shown that obese patients undergoing treat-
ment with satiatedmeal showed less activity in DLPFC compared to
lean men [66e72]. It was also observed that obese women dis-
played less activation in the left DLPFC compared to lean and ex-
obese women [69]. In addition, there were no differences in the
brain activity of lean and ex-obese subjects, suggesting that the
normalization of left DLPFC activity may occur after weight loss or
there is a pre-existing endophenotype of subjects who are able to
lose weight [72].
In this way, the manipulation of cerebral activity might be able
to rebalance and translate it in beneficial behavioral changes, such
as limiting the food intake [73]. Thus, new innovative approaches
are necessary to promote behavioral changes, leading to successful
weight loss, such as transcranial direct current stimulation (TDCS).
This technique is a noninvasive neuromodulation methodology
where a constant, low-intensity electrical current applied to the
cortex through surface electrodes positioned on the scalp, with two
different currents, anodal (excitatory) and cathodal (inhibitory)
[74]. TDCS changes the spontaneous rates of neuronal discharge
[75] by increasing or decreasing cortical excitability [76]. Its
repeated application (i.e., consecutive days) may lead to long-term
effects, resulting from synaptic changes involving the LTD and LTP
process [53]. DLPFC plays an important role in the organization and
planning of behavior [65]. Dysregulation of left DLPFC in obese
subjects is likely to undermine regulation of dietary behavior and
food choice, suggesting this region as a key target for obesity
intervention. Experimental interventions in the left DLPFC could
therefore add new understanding about this relationship, leading
to new possibilities of treatments for weight loss [77].
Recently, several studies have revealed interesting findings
stimulating DLPFC. For example, reports have shown reduced food
craving [78e80], and food intake [81,82] after 1 or more tDCS
sessions aimed at improving left [78e83] and right [80] DLPFC
activity. However, none of these studies investigated the effect of
tDCS directly on body weight loss, since only one session of tDCS
was applied [78e83]. According to our knowledge, only two studies
had longer duration than the other studies [84,85]. In a single-
blind, randomized, placebo-controlled crossover study, Gluck and
colleagues [84] examined the effects of anodal-tDCS applied to left
DLPFC for 40 min at 2 mA on food consumption in overweight/
obeses subjects and found a significant decrease in food con-
sumption (i.e., calories and fat) compared to cathodal-tDCS, but no
effects compared to sham-tDCS. The second study investigated the
effects of anodal-tDCS applied to right DLPFC on food cravings in
obese subjects [85]. Anodal-tDCS was applied for five consecutive
days at 2 mA during 20 min, as well as sham-tDCS that included
anodal-tDCS only in the first day followed by sham-tDCS. Authors
found significant reduction in craving followed anodal-tDCS, but
not to sham, and the reduction achieved remained for a full 25 days
after the end of treatment.
The big challenge in obesity treatment is reach brain regions
supporting eating behavior, which are located in deep brain zones.
It is unclear whether tDCS could be reliability, sensitivity and
specificity for deep areas [86]. tDCS is more useful for cortical areas,
specially DLPFC, responsible for important cognitive functions, such
as eating behavior. Future studies should examine in detail the
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these subjects and, based on this information, design tDCS in-
terventions to induce similar brain patterns in refractory obese
subjects. This novel approach will likely require multiple sessions
and high-intensity stimulation schemes, as long as safety is not
compromised.Fig. 2. Strategies to treat obesity. Non-pharmacological/invasive therapies to treat obesity
direct current stimulation. Although positive results have been reported by using these tech
accelerate loss weight in obese patients than applying separately these interventions.4. Concluding remarks
According to the World Health Organization, obesity is a
pandemic issue [1]. It is acceptable that excessive energy intake
that exceeds energy expenditure is one of the main causes
of this disturbance. Multiple therapeutically strategies have beeninclude the use of diets, cognitive-behavioral interventions, exercise and transcranial
niques, no current evidence is available whether combination of these approaches may
M.F. Higuera-Hernandez et al. / Clinical Nutrition ESPEN 25 (2018) 50e5554developed aimed to manage and prevent this health issue. From
approaches including drugs or surgical procedures, obesity has
become one serious health problem in modern society that needs
to be addressed with urgent [18,87e91]. However, obesity has
become a complex health problem since multiple elements
participate in the onset of this disease. Here, we highlighted the use
of non-pharmacological/invasive techniques used to manage
obesity, such as diets, cognitive behavioral intervention, exercise
and transcranial direct current stimulation (Fig. 2).
Despite the positive outcomes of using these interventions
have been reported, no solid evidence is available whether com-
bination of these techniques may allow loss weight in obese pa-
tients in a more effective fashion than applying by separate these
interventions. Thus, further evidence is needed to address this
concern.
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